AMIODARONE HCL
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
AHP
Drug class
Antiarrhythmic - Class III
Class III antiarrhythmics are a functional category of cardiovascular medications defined under the Vaughan Williams classification system. Read more about Antiarrhythmic - Class III
79 drugs in this class 59 manufacturers
Drugs in Antiarrhythmic - Class III
PACERONE (amiodarone HCl)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
Upsher-Smith Laboratories
TIKOSYN (dofetilide)
ANTIARRHYTHMIC - CLASS III · CARDIOVERSION OF ATRIAL FIBRILLATION ·+2
Parke-Davis Pfizer
NEXTERONE (amiodarone in dextrose, iso-osmotic)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
Baxter Healthcare Company
AMIODARONE HCL
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
SAGENT PHARMACE
SOTALOL AF (sotalol HCl)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
Mylan Pharmaceuticals
MULTAQ (dronedarone HCl)
ANTIARRHYTHMIC - CLASS III · PAROXYSMAL ATRIAL FIBRILLATION ·+1
Sanofi-Aventis U.S.
SOTALOL AF (sotalol HCl)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
Mylan Pharmaceuticals
SOTALOL (sotalol HCl)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
TEVA USA
Filter & compare in the drug finder →
Opens the drug finder with Antiarrhythmic - Class III preselected. Add indication or manufacturer filters there.
Class III antiarrhythmics are a functional category of cardiovascular medications defined under the Vaughan Williams classification system.
These agents work predominantly by blocking cardiac potassium channels, which delays phase 3 repolarization and lengthens both the myocardial action potential duration and the effective refractory period without significantly slowing conduction velocity.
Clinically, they are utilized to terminate and prevent various tachyarrhythmias, most notably atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation.
Commonly used agents within this therapeutic class include amiodarone, sotalol, dofetilide, and ibutilide.
-
cvpharmacology.com
These agents work predominantly by blocking cardiac potassium channels, which delays phase 3 repolarization and lengthens both the myocardial action potential duration and the effective refractory period without significantly slowing conduction velocity
-
nih.gov
These agents work predominantly by blocking cardiac potassium channels, which delays phase 3 repolarization and lengthens both the myocardial action potential duration and the effective refractory period without significantly slowing conduction velocity
-
nih.gov
Clinically, they are utilized to terminate and prevent various tachyarrhythmias, most notably atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation
-
nih.gov
Clinically, they are utilized to terminate and prevent various tachyarrhythmias, most notably atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation
-
nih.gov
Clinically, they are utilized to terminate and prevent various tachyarrhythmias, most notably atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation
-
amboss.com
Commonly used agents within this therapeutic class include amiodarone, sotalol, dofetilide, and ibutilide
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.